TY - JOUR AU - Bassetti, Matteo AU - Giacobbe, Daniele Roberto PY - 2019 TI - Reducing dissemination of carbapenem-resistant Klebsiella pneumoniae JF - Annals of Translational Medicine; Vol 7, Supplement 8 (December 31, 2019): Annals of Translational Medicine Y2 - 2019 KW - N2 - Besides being resistant to several β-lactams, carbapenem-resistant Klebsiella pneumoniae (CRKP) are often resistant to other widely used antimicrobials such as fluoroquinolones and cotrimoxazole, and sometimes to aminoglycosides (1,2). Although possibly not the only reason, the increased risk of delayed/suboptimal treatment consequent to the multidrug-resistant phenotype of CRKP is a major contributor to the high mortality of CRKP infections (3-7). UR - https://atm.amegroups.org/article/view/29648